| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.12B | +14.5% |
| Cost of Revenue | $2.39B | +18.2% |
| Gross Profit | $4.73B | +12.7% |
| R&D Expense | $998.8M | +13.6% |
| SG&A Expense | $1.96B | +12.9% |
| Operating Income | $1.77B | +12.0% |
| Pre-tax Income | $1.96B | +21.9% |
| Income Tax | $141.6M | -46.0% |
| Net Income | $1.80B |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.75B | +73.9% |
| Short-term Investments | $2.47B | -2.5% |
| Accounts Receivable | $1.13B | +20.0% |
| Inventory | $1.22B | +36.7% |
| Current Assets | $7.89B | +26.1% |
| Total Assets | $15.44B | +19.0% |
| Current Liabilities | $1.66B | +16.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.81B | +21.7% |
| Investing Cash Flow | -$360.1M | -126.3% |
| Financing Cash Flow | -$287.6M | +88.8% |
| +36.0% |
| EPS (Basic) | $5.12 | +37.6% |
| EPS (Diluted) | $5.03 | +37.8% |
| Total Liabilities |
| $2.04B |
| +9.8% |
| Stockholders' Equity | $13.31B | +20.5% |